Novel class of drug for ovarian cancer
24 Nov 2011
Novel class of drug for ovarian cancer
Understanding tumour metastasis
Toxicity and side effect prevention
Lifetime achievement award and future work
Modelling cancer genomes
Chromosome instability in cancer development
RAS and drugable targets
New epigenetic targets and the role of DNA methylation fingerprints in cancer treatment
Highlights from day two of the 5th International Workshop
Highlights from day one of the 5th International Workshop
2011 St Gallen Consensus breast cancer recommendations
A new light activated technique for delivery of anti-cancer drugs